Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liushen Capsule is a Traditional Chinese Medicine (TCM) product based on the classic Liushen Wan formula, widely used in China for its potent anti-inflammatory, analgesic, and detoxifying properties. It is primarily indicated for the treatment of acute pharyngitis, tonsillitis, and other inflammatory conditions of the throat and skin. The formulation is a complex mixture of six traditional ingredients: *Venenum Bufonis* (toad venom), *Calculus Bovis* (ox gallstone), *Moschus* (musk), *Margarita* (pearl), *Borneolum Syntheticum* (borneol), and *Realgar* (arsenic sulfide). Its mechanism of action involves the inhibition of pro-inflammatory mediators and the modulation of sodium-potassium ATPase by bufadienolides, alongside antimicrobial activity provided by realgar. Modern clinical research, including real-world evidence studies, continues to validate its efficacy in managing throat pain and swelling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Liushen Capsule.